Epoetin alpha

DRUG5 trials

Sponsors

University of Medicine and Dentistry of New Jersey, University Medical Center Groningen, Azidus Brasil, University of Iowa

Conditions

AnemiaCABGChronic Kidney DiseaseCoronary Artery DiseaseIschemia-Reperfusion InjuryMyocardial InfarctionNeonatal Anemia

Phase 2

Study of the Use of a Single Dose of Erythropoietin to Treat Acute Myocardial Ischemia

CompletedNCT00524901

University Medical Center GroningenCABG, Coronary Artery Disease

Start: 2007-09-30End: 2011-04-30Updated: 2013-02-15

Optimized Erythropoietin (EPO) Treatment

CompletedNCT02075970

University of IowaNeonatal Anemia

Start: 2014-06-01End: 2019-12-01Updated: 2026-07-23

Phase 3

Clinical Efficacy of Two Erythropoietin Drug in Participants With Secondary Anemia to Chronic Kidney Disease.

TerminatedNCT01695759

Azidus BrasilAnemia, Chronic Kidney Disease

Start: 2013-12-31End: 2018-01-31Updated: 2018-08-20

Phase 4

Prevalence and Treatment of Anemia in Rehabilitation Patients

TerminatedNCT00511901

University of Medicine and Dentistry of New JerseyAnemia

Start: 2005-11-30End: 2008-05-31Updated: 2014-01-31

Unknown Phase

Infusion of a Single Dose of Erythropoietin to Prevent Injury in an Ischemia Reperfusion Forearm Model

University Medical Center GroningenIschemia-Reperfusion Injury, Myocardial Infarction

Start: 2010-07-31End: 2011-12-31Target: 12Updated: 2010-03-12